Aldeyra Therapeutics, Inc. (ALDX)
5.35
+0.10
(+1.90%)
USD |
NASDAQ |
Feb 13, 14:14
Aldeyra Therapeutics Cash from Investing (Quarterly) : 25.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| MediciNova, Inc. | -0.0029M |
| Altimmune, Inc. | -149.32M |
| Actinium Pharmaceuticals, Inc. | 0.00 |
| Avanos Medical, Inc. | -31.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.021M |
| Cash from Financing (Quarterly) | 0.1207M |
| Free Cash Flow | -40.08M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -7.009M |
| Free Cash Flow to Firm (Quarterly) | -6.546M |
| Free Cash Flow Yield | -12.51% |